Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer (Q50506494)
scientific article published on December 1, 1997
Language:
(P31) (Q13442814)
(P304) 1269-1271
(P407) (Q1860)
(P433) 12
(P478) 8
(P577) Monday, December 1, 1997
Monday, December 1, 1997
(P921) (Q412415)
(P953) https://doi.org/10.1023/a:1008219125746
https://api.elsevier.com/content/article/PII:S0923753419640718?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419640718?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/8/12/1269/19480569/8-12-1269.pdf
(P1433) (Q326122)
(P1476) "Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer" (language: en)
(P2093) V. A. Miller
K. K. Ng
S. C. Grant
H. Kindler
B. Pizzo
R. T. Heelan
R. von Roemeling
M. G. Kris
(P2860) (Q37638262)
(Q35976983)
(Q68198522)
(Q67941709)
other details
description scientific article published on December 1, 1997

External Links